Qiming Venture Partners has led a $20 million round for New Horizon Health, a Chinese start-up that develops cancer screening technology, with participation from existing investors Legend Capital and SBCVC.
Founded in 2005, New Horizon has created a tool for screening stool samples and identifying changes in cell DNA that might be early signs of colon cancer. The company claims this is a more efficient detection...
Baird Capital has acquired a minority stake in Nirvana Asia, a funeral services business that was privatized by CVC Capital Partners in 2016 in conjunction with the company’s founder.
Chinese PE firm Yunfeng Capital and Hong Kong-listed medical device manufacturer MicroPort Scientific Corporation will acquire US-listed LivaNova's cardiac rhythm management (CRM) business for $190 million in cash.
Emerging markets private capital fundraising – led by emerging Asia – reached its highest point since the before the global financial crisis in 2017, according to EMPEA, with capital dispersed more evenly across different strategies than ever before.
KKday, a Taiwan-based start-up that helps tourists find local activities, has secured $10.5 million Series B round of funding led by Japanese travel agent HIS, with participation from existing backer MindWorks Ventures.